Unicycive Therapeutics Inc (UNCY:NASDAQ)

$6.59 -0.24 (-3.51%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Unicycive Therapeutics Inc (UNCY:NASDAQ) News Sources

Alembic enters US branded pharma space; commences sale of antibiotic

The Hindu BusinessLine

external link

Chronic Kidney Disease Market Competitive Landscape Report 2026: Comprehensive Insights About 75+ Companies and 95+ Drugs by Product Type, Stage, Route of Administration, and ...

Yahoo Finance UK

external link
UNCY stock
UNCY stock price
UNCY stock price today
UNCY stock prediction
UNCY earnings date
UNCY news
UNCY price
UNCY share
UNCY share price
UNCY shares
UNCY ceo
UNCY premarket
$UNCY
UNCY ticker
UNCY after hours
UNCY stock
UNCY stock price
UNCY stock price today
UNCY stock prediction
UNCY earnings date
UNCY news
UNCY price
UNCY share
UNCY share price
UNCY shares
UNCY ceo
UNCY premarket
$UNCY
UNCY ticker
UNCY after hours

Unicycive Therapeutics Inc (UNCY:NASDAQ) FAQs

toggle

What is the current price of Unicycive Therapeutics Inc (UNCY:NASDAQ)?

The current price of Unicycive Therapeutics Inc (UNCY:NASDAQ) is $6.59.


toggle

Unicycive Therapeutics Inc (UNCY:NASDAQ) absolute price change since previous trading day?

The absolute price change of Unicycive Therapeutics Inc (UNCY:NASDAQ) since the previous trading day is $-0.24.


toggle

Unicycive Therapeutics Inc (UNCY:NASDAQ) percentage price change since previous trading day?

The percentage price change of Unicycive Therapeutics Inc (UNCY:NASDAQ) since the previous trading day is -3.51%.


toggle

What is This Week's average sentiment score for Unicycive Therapeutics Inc (UNCY:NASDAQ)?

This Week's average sentiment score for Unicycive Therapeutics Inc (UNCY:NASDAQ) is 79 out of 100.


toggle

What is This Week's average sentiment for Unicycive Therapeutics Inc (UNCY:NASDAQ)?

This Week's sentiment for Unicycive Therapeutics Inc (UNCY:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.